Quince Therapeutics Presents Preclinical Data at OI 2022 Demonstrating Potential of a Targeted Anabolic for Accelerated Bone Healing of Osteogenesis Imperfecta FracturesBusiness Wire • 08/30/22
Quince Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022Business Wire • 08/04/22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate NameBusiness Wire • 08/01/22